Antiverse, a techbio company designing antibodies for challenging targets, today announced it has added £3.5 M ($4.6 M) to its seed funding.
From AntiverseOct 16 2024 Antiverse, a techbio company designing antibodies for challenging targets, today announced it has added £3.5 M to its seed funding. The investment will facilitate the Company’s growth, including appointments to strengthen the team and continued development of its antibody design programmes, many in partnership with pharmaceutical companies.
The funding will be used to expand the Company’s laboratory and machine learning teams, bolstering the development of its internal assets against G-protein-coupled receptors and ion channels towards the clinic, as well as facilitating ongoing collaborations with pharma and biotech companies. The funding will also be used to improve the predictive accuracy of the design platform, focusing on curating training data.
Antiverse uses a machine-learning-centred approach to design antibodies for challenging targets, helping to bring needed therapies to patients. The current version of the platform uses ‘target-specific libraries’. These libraries are designed by using structural and sequence data to generate a library with high confidence against the target.
A third of all FDA-approved drugs target GPCRs, yet, despite decades of research and billions of funding, only a few GPCR-targeting antibodies exist. Thanks to the support of our investors, we are one step closer to making GPCRs and other challenging targets druggable, bringing needed therapies to patients across the globe.” Jaromir Zahradka, CEO at i&i Bio, commented: “Antiverse has made significant progress in the field of antibody design.
John Gebeily, Operating Partner at Kadmos Capital, added: “Antiverse's AI-driven antibody design platform demonstrates significant potential in advancing the development of novel antibody therapeutics, particularly for complex drug targets. We're excited to support Murat and the team in their effort to significantly accelerate the development of life-saving treatments, and have a transformative impact on the pharmaceutical industry.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Plans for Devon energy storage facility rejectedCouncillors raise concerns about the effect on the landscape of another renewable energy project.
Read more »
Dad completes 'world's hardest triathlon' in new record timePaul Robinson ran, swam and cycled from London to Paris to raise money to fight MND.
Read more »
Airdrie schoolboy, eight, scales Ben Nevis to raise more than £3k for hospiceHarris Skene, of All Saints Primary School, was, by some distance, the youngest participant to complete the 4413-foot challenge.
Read more »
Glasgow hospice can sell alcohol to raise funds despite health chiefs' concernsThe city's health and social care partnership believes selling alcohol from The Prince and Princess of Wales Hospice site is unsuitable. A spokeswoman said alcohol is a “carcinogen”.
Read more »
Kevin Day to walk over 60 miles for Surrey charityKevin Day will walk via 13 football stadiums to raise money for mitochondrial disease.
Read more »
Ballet star Reece Clarke's Airdrie shows raise £11,000 for Guide DogsThe bumper cheque was handed over to staff and service users at the charity's base in Hamilton
Read more »